• NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

    11 days ago - By News Medical

    The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.
    Read more ...